Market revenue in 2023 | USD 527.7 million |
Market revenue in 2030 | USD 1,266.4 million |
Growth rate | 13.3% (CAGR from 2023 to 2030) |
Largest segment | Reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Kits, Instruments, Enzymes, Services |
Key market players worldwide | Roche Holding AG, Thermo Fisher Scientific Inc, Eisai Co Ltd, Novartis AG ADR, Element Biosciences, Dovetail Genomics, Illumina Inc, Promega, Abcam PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epigenetics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 34.58% in 2023. Horizon Databook has segmented the Italy epigenetics market based on reagents, kits, instruments, enzymes, services covering the revenue growth of each sub-segment from 2018 to 2030.
The Italy epigenetics Market is growing and is driven by strategic funding initiatives. According to an article by the LA biotech UG, Sofinnova's Partners invested €6 million (USD 6,588 million) in Italian gene therapy companies, further solidifying Italy's status as a key hub for cell and gene therapies in Europe.
The financial backing, directed through Sofinnova's Telethon Fund, supported AA Vantgarde Bio, Alia Therapeutics, and Borea Therapeutics, providing seed capital (USD 6,588 million) for the development of treatments targeting rare genetic diseases.
Established in collaboration with the Telethon Foundation charity, Sofinnova's Telethon Fund has stood as Italy's largest investment pot for biotechnology since 2018. Over three decades, the Telethon Foundation has been instrumental in supporting research for new treatments for rare & genetic disorders, contributing to the thriving landscape of gene therapy startups and academic excellence in Italy.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy epigenetics market , including forecasts for subscribers. This country databook contains high-level insights into Italy epigenetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account